Nephros, Inc.NEPHNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+11.7%
5Y CAGR+14.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+11.7%/yr
vs +20.5%/yr prior
5Y CAGR
+14.9%/yr
Recent deceleration
Acceleration
-8.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.30M | +34.3% |
| 2024 | $5.44M | -6.8% |
| 2023 | $5.83M | +11.2% |
| 2022 | $5.24M | +14.4% |
| 2021 | $4.58M | +25.7% |
| 2020 | $3.65M | -14.2% |
| 2019 | $4.25M | +71.1% |
| 2018 | $2.48M | +63.7% |
| 2017 | $1.52M | +47.9% |
| 2016 | $1.03M | - |